The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131

BACKGROUND: It is important to simultaneously induce strong cell death and antitumor immunity in cancer patients for successful cancer treatment. Here, we investigated the cytotoxic and phenotypic modulation effects of the combination of ANT2 shRNA and human sodium iodide symporter (hNIS) radioiodin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Choi, Yun, Lee, Ho Won, Lee, Jaetae, Jeon, Yong Hyun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2013
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3653759/
https://ncbi.nlm.nih.gov/pubmed/23522027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-143
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak